aminolevulinic acid has been researched along with Blood Pressure, High in 14 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings suggest that 5-ALA-HCl does not affect the antihypertensive agents-induced hypotensive effect, but enhances the bupivacaine-induced hypotensive effect, especially in SHRs, indicating that 5-ALA may contribute to anesthesia-induced hypotension via suppression of sympathetic nerve activity in patients with hypertension." | 8.31 | 5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats. ( Abe, M; Fukuda, N; Hara, T; Ishizuka, M; Ito, H; Katakawa, M; Otsuka, N, 2023) |
| "The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase." | 5.41 | AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. ( Balwani, M; Bonkovsky, HL; Lim, JK; Wang, B, 2023) |
| "Arterial hypertension was defined as the blood pressure over 140/90 and/or early diagnosed hypertension." | 5.31 | [Influence of lead exposure on arterial hypertension]. ( Birkner, E; Dziwisz, M; Kasperczyk, A; Kasperczyk, S, 2002) |
| "These findings suggest that 5-ALA-HCl does not affect the antihypertensive agents-induced hypotensive effect, but enhances the bupivacaine-induced hypotensive effect, especially in SHRs, indicating that 5-ALA may contribute to anesthesia-induced hypotension via suppression of sympathetic nerve activity in patients with hypertension." | 4.31 | 5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats. ( Abe, M; Fukuda, N; Hara, T; Ishizuka, M; Ito, H; Katakawa, M; Otsuka, N, 2023) |
| "5-aminolevulinic acid hydrochloride is a highly effective drug in reducing tumor residuals in transurethral resection of the bladder tumors; however, hypotension is a serious side effect that causes clinical problems." | 4.31 | [Effectiveness of Pharmaceutical Intervention While Administering 5-Aminolevulinic Acid Hydrochloride through a Collaboration of Physicians and Pharmacists]. ( Aoyama, S; Kasahara, S; Komeda, H; Mizui, T; Tachi, T; Takai, A; Tanaka, K; Yasuda, M, 2023) |
| "However, pain and hypertension are important side effects of conventional PDT (c-PDT)." | 3.11 | Hemodynamic changes during conventional and daylight photodynamic therapy of actinic keratoses - a randomized controlled trial. ( Enk, A; Gholam, P; Hartmann, J; Keller, A, 2022) |
| "Pain was quantified using a visual analog scale." | 3.11 | Hemodynamic changes during conventional and daylight photodynamic therapy of actinic keratoses - a randomized controlled trial. ( Enk, A; Gholam, P; Hartmann, J; Keller, A, 2022) |
| "Acute intermittent porphyria is the most common type of AHP, with an estimated prevalence of patients with symptoms of approximately 1 in 100,000." | 3.01 | AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. ( Balwani, M; Bonkovsky, HL; Lim, JK; Wang, B, 2023) |
| "The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase." | 3.01 | AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. ( Balwani, M; Bonkovsky, HL; Lim, JK; Wang, B, 2023) |
| "Headache is common in PRES, though headache associated with PRES was not identified as a separate entity in the 2018 International Classification of Headache Disorders." | 2.72 | Posterior Reversible Encephalopathy Syndrome. ( Gao, V; Gewirtz, AN; Parauda, SC; Robbins, MS, 2021) |
| "Associations with PRES include renal failure, preeclampsia and eclampsia, autoimmune conditions, and immunosuppression." | 2.72 | Posterior Reversible Encephalopathy Syndrome. ( Gao, V; Gewirtz, AN; Parauda, SC; Robbins, MS, 2021) |
| "5-aminolevulinic acid hydrochloride is a highly effective drug in reducing tumor residuals in transurethral resection of the bladder tumors; however, hypotension is a serious side effect that causes clinical problems." | 1.91 | [Effectiveness of Pharmaceutical Intervention While Administering 5-Aminolevulinic Acid Hydrochloride through a Collaboration of Physicians and Pharmacists]. ( Aoyama, S; Kasahara, S; Komeda, H; Mizui, T; Tachi, T; Takai, A; Tanaka, K; Yasuda, M, 2023) |
| "Arterial hypertension was defined as the blood pressure over 140/90 and/or early diagnosed hypertension." | 1.31 | [Influence of lead exposure on arterial hypertension]. ( Birkner, E; Dziwisz, M; Kasperczyk, A; Kasperczyk, S, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 6 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Keller, A | 2 |
| Hartmann, J | 2 |
| Enk, A | 2 |
| Gholam, P | 2 |
| Wang, B | 1 |
| Bonkovsky, HL | 1 |
| Lim, JK | 1 |
| Balwani, M | 1 |
| Fukuda, N | 1 |
| Katakawa, M | 1 |
| Ito, H | 1 |
| Hara, T | 1 |
| Otsuka, N | 1 |
| Ishizuka, M | 1 |
| Abe, M | 1 |
| Tanaka, K | 1 |
| Tachi, T | 1 |
| Takai, A | 1 |
| Aoyama, S | 1 |
| Yasuda, M | 1 |
| Kasahara, S | 1 |
| Komeda, H | 1 |
| Mizui, T | 1 |
| Gewirtz, AN | 1 |
| Gao, V | 1 |
| Parauda, SC | 1 |
| Robbins, MS | 1 |
| Borroni, RG | 1 |
| Carugno, A | 1 |
| Rivetti, N | 1 |
| Arbustini, E | 1 |
| Brazzelli, V | 1 |
| Pallet, N | 1 |
| Mami, I | 1 |
| Schmitt, C | 1 |
| Karim, Z | 1 |
| François, A | 1 |
| Rabant, M | 1 |
| Nochy, D | 1 |
| Gouya, L | 1 |
| Deybach, JC | 1 |
| Xu-Dubois, Y | 1 |
| Thervet, E | 1 |
| Puy, H | 1 |
| Karras, A | 1 |
| Bourque, SL | 1 |
| Benjamin, CD | 1 |
| Adams, MA | 1 |
| Nakatsu, K | 1 |
| Nomiyama, K | 1 |
| Nomiyama, H | 1 |
| Liu, SJ | 1 |
| Tao, YX | 1 |
| Nomiyama, T | 1 |
| Omae, K | 1 |
| Kasperczyk, S | 2 |
| Dziwisz, M | 1 |
| Kasperczyk, A | 2 |
| Birkner, E | 2 |
| Kasperczyk, J | 1 |
| Boscolo, P | 1 |
| Galli, G | 1 |
| Iannaccone, A | 1 |
| Martino, F | 1 |
| Porcelli, G | 1 |
| Troncone, L | 1 |
| Carvalho, L | 1 |
| Soares, MA | 1 |
| da Costa, JN | 1 |
2 reviews available for aminolevulinic acid and Blood Pressure, High
| Article | Year |
|---|---|
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Topics: Abdominal Pain; Aminolevulinic Acid; Antiemetics; Carcinoma, Hepatocellular; Creatinine; Female; Hem | 2023 |
Posterior Reversible Encephalopathy Syndrome.
Topics: Acute Chest Syndrome; Aminolevulinic Acid; Anemia, Sickle Cell; Autoimmune Diseases; Blood-Brain Bar | 2021 |
1 trial available for aminolevulinic acid and Blood Pressure, High
| Article | Year |
|---|---|
Hemodynamic changes during conventional and daylight photodynamic therapy of actinic keratoses - a randomized controlled trial.
Topics: Aminolevulinic Acid; Hemodynamics; Humans; Hypertension; Keratosis, Actinic; Pain; Photochemotherapy | 2022 |
11 other studies available for aminolevulinic acid and Blood Pressure, High
| Article | Year |
|---|---|
Pulse rate and blood pressure changes during low-irradiance PDT compared with conventional PDT in the treatment of facial actinic keratoses: A retrospective study.
Topics: Aminolevulinic Acid; Blood Pressure; Heart Rate; Humans; Hypertension; Keratosis, Actinic; Pain; Pho | 2022 |
5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats.
Topics: Aminolevulinic Acid; Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Bupivacaine; Hype | 2023 |
[Effectiveness of Pharmaceutical Intervention While Administering 5-Aminolevulinic Acid Hydrochloride through a Collaboration of Physicians and Pharmacists].
Topics: Aminolevulinic Acid; Antihypertensive Agents; Humans; Hypertension; Hypotension; Pharmaceutical Prep | 2023 |
Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Blood Pressure; Bowen's Disease; Carcinom | 2013 |
High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.
Topics: Aged; Aminolevulinic Acid; Apoptosis; Cells, Cultured; Endoplasmic Reticulum Stress; Epithelial Cell | 2015 |
Lack of hemodynamic effects after extended heme synthesis inhibition by succinylacetone in rats.
Topics: Aminolevulinic Acid; Animals; Blood Pressure; Guanylate Cyclase; Heme; Hemodynamics; Heptanoates; Hy | 2010 |
Lead induced increase of blood pressure in female lead workers.
Topics: Adolescent; Adult; Aminolevulinic Acid; Blood Pressure; Confounding Factors, Epidemiologic; Dose-Res | 2002 |
[Influence of lead exposure on arterial hypertension].
Topics: Adult; Age Factors; Air Pollutants, Occupational; Aminolevulinic Acid; Blood Pressure; Body Mass Ind | 2002 |
Lipids, lipid peroxidation and 7-ketocholesterol in workers exposed to lead.
Topics: Adult; Aminolevulinic Acid; Erythrocytes; Humans; Hypertension; Industry; Ketocholesterols; Lead Poi | 2005 |
Plasma renin activity and urinary kallikrein excretion in lead-exposed workers as related to hypertension and nephropathy.
Topics: Adult; Aging; Aminolevulinic Acid; Creatinine; Humans; Hypertension; Kallikreins; Kidney Diseases; L | 1981 |
[Lead reassessed as an etiological factor in arterial hypertension].
Topics: Adult; Aminolevulinic Acid; Edetic Acid; Humans; Hypertension; Lead; Lead Poisoning; Male; Middle Ag | 1985 |